Modalities in Modern R&D: Choosing Between Small Molecules, Biologics, and ATMPs—Quality, CMC, and Regulatory Pathways
Modalities in Modern R&D: Choosing Between Small Molecules, Biologics, and ATMPs—Quality, CMC, and Regulatory Pathways Picking the Right Modality: How Small Molecules, Biologics, and ATMPs Shape Quality, CMC, and Regulatory Strategy Modality as a strategic choice: linking biology, manufacturability, quality, and speed Every program begins with biology, but it succeeds—or struggles—based on modality. Mechanism, tissue…